Advertisement
Advertisement
NTLA
Intellia Therapeutics, Inc
12.26
USDSponsored
+0.77
+6.70%
Sep 17, 16:00 UTC -4
Closed
After-Market
12.39
+0.13
+1.05%
Intellia Therapeutics, Inc Financial Snapshot
| Market Cap | 1.74B |
| Beta | 1.82 |
| Earnings Per Share (EPS) | -3.36 |
| Price-to-Book (P/B) Ratio | 2.18 |
| Operating Margin | -672.16% |
| Total Debt/Equity (D/E) | 0.00% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -57.79% |
| Current Ratio | 6.65% |
| Free Cash Flow | -202.26M |
